Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes (Q2912356)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes |
scientific article; zbMATH DE number 6082631
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes |
scientific article; zbMATH DE number 6082631 |
Statements
14 September 2012
0 references
fitting prior
0 references
partial borrowing power prior
0 references
sampling prior
0 references
simulation
0 references
survival data
0 references
0 references
Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes (English)
0 references
0.6861515045166016
0 references
0.668572187423706
0 references
0.6681491136550903
0 references
0.6653018593788147
0 references
